Afyx Development A/S: Financial statements 2018
CVR: 35839739
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Afyx Development A/S (CVR 35839739) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -37,626,044 and a net result of DKK -45,055,310 compared with DKK -25,565,389 the year before. Equity in the 2018 report amounted to DKK 54,231,523. The solvency ratio was 87.2%. The company had 8 employees in the financial year.
- Gross Profit
- DKK -37,626,044
- Profit/Loss
- DKK -45,055,310
- Equity
- DKK 54,231,523
- Total Assets
- DKK 62,161,030
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -37.6 mio. | -45.1 mio. | 54.2 mio. | 8 |
| 2017 | - | -23.4 mio. | -25.6 mio. | 99.3 mio. | 3 |
| 2016 | - | -10.1 mio. | -9.3 mio. | 6.4 mio. | 1 |
| 2015 | - | -1.8 mio. | -1.5 mio. | 11.6 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of December 21, 2018, Jens Hansen has left the board of directors of Afyx Development A/S.
As of November 19, 2018, Nishan de Silva is registered as adm. dir. of Afyx Development A/S.
As of November 19, 2018, Jens Hansen has stepped down as adm. dir. of Afyx Development A/S.
Afyx Development A/S has published its annual report for 2017. Gross profit came to DKK -23,387,750, and the net result was DKK -25,565,389.
About Afyx Development A/S
Afyx Development A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Juan Møller-San Pedro. The board consists of Ole Baadsgaard (chair), Claus Juan Møller-San Pedro, Pia Leah Møller-San Pedro and Søren Mohrsen Kjær. The company is owned by Afyx Therapeutics A/S. The company has 8 employees (2018). In 2025, the company reported a gross profit of DKK -5,044,782 and a net result of DKK -4,260,251 compared with DKK -6,896,490 the year before. Equity in the 2025 report amounted to DKK -7,253,987.